virus entry sites in the peripheral blood to T cell-rich areas in lymphoid tissues. Intimate contact between DCs and T cells has been shown to promote transmission of HIV-1 by locally concentrating virus, viral receptors, and coreceptors, as well as certain adhesion molecules. Previous studies have provided evidence that, in addition to CD4 and chemokine receptors CCR5 and CXCR4, DC-SIGN (DC-specific intercellular adhesion molecule 3-grabbing nonintegrin; also called "CD209") is largely responsible for the capture of HIV-1 and the amplification of the infection in the DC-T cell milieu [1] . In contrast to CD4, which is the primary cellular receptor, DC-SIGN functions not as a classical HIV-1 entry receptor but rather as a transreceptor that binds to HIV-1 and transfers the virus very efficiently to neighboring permissive target cells [1] . Recently, it has been discovered that DC-SIGN is also exploited by protozoan parasites of the genus Leishmania, which are opportunistic pathogens in HIV-1 infection, to gain entry into DCs [2] . Leishmania/HIV-1 coinfection is considered to be a serious threat in countries where both pathogens are widespread. This parasite has been shown not only to up-regulate HIV-1 transcription and virus production [3] but also to down-regulate HIV-1-mediated giant cell formation [4] , which suggests that there is a complex relationship between the 2 microorganisms. Leishmania pifanoi and Leishmania infantum amastigotes can infect DCs, because these parasites can efficiently bind to DC-SIGN [2] . It has been proposed that DCs will carry the bound parasites during their migration from the initial infection sites to the most proximal draining lymph nodes, an event contributing to the establishment of a parasite reservoir.
Despite the reported propensity of both HIV-1 and Leishmania parasites to utilize DC-SIGN as a portal of entry into DCs, the consequences of these findings for HIV-1 capture and transfer have not been previously investigated. By use of both DC-SIGN transfectants and primary human immature DCs, we demonstrate here that ligation of L. infantum amastigotes to DC-SIGN leads to reduced retention and transfer of HIV-1.
Methods. Virions were produced by transient calcium phosphate transfection of human 293T cells with the R5-tropic HIV-1 infectious molecular clone JR-CSF, and virus stocks were normalized for virion content, as described elsewhere [5] . Stationary L. infantum promastigotes were transferred into MAA/20 medium that consisted of modified medium 199 (Gibco BRL) with Hank's salts, supplemented with 0.5% soybean trypto-casein (Pasteur Diagnostics), 15 mmol/L d-glucose, 5 mmol/L l-glutamine, 4 mmol/L NaHCO 3 , 0.023 mmol/L bovine hemin, 25 mmol/L HEPES (pH, 6.5), and 20% fetal bovine serum, to differentiate 
them into amastigotes. Axenically grown L. infantum amastigotes were maintained at 37ЊC in a 5% CO 2 atmosphere by weekly subpassages in MAA/20. Cells used in the present study include human immature monocyte-derived DCs (iMDDCs), human CD4 + T cells, a DC-SIGN-transfected cell line (B-THP-1/DC-SIGN) and its wild-type counterpart (B-THP-1), and an indicator cell line (TZM-bl). Primary human iMDDCs and CD4 + T cells were generated from peripheral blood mononuclear cells from healthy donors by means of Ficoll-Hypaque (Cellgro) centrifugation, as described elsewhere [6] . The DC-SIGN + B-THP-1/DC-SIGN cell line has been described elsewhere [7] . The TZM-bl indicator cell line is a genetically modified HeLa cell line expressing large amounts of cell-surface CD4 and CCR5. These cells carry separate integrated copies of the luciferase and b-galactosidase genes under the control of the HIV-1 promoter and are highly sensitive to infection with different HIV-1 variants [8] .
Flow cytometry analysis was performed to test the binding of L. infantum amastigotes to B-THP-1/DC-SIGN cells. Briefly, cells were either left untreated or exposed to L. infantum amastigotes for 1 h at 37ЊC to reach the saturation state and were subsequently washed with PBS to eliminate unbound parasites. Cells were then stained with a fluorescein isothiocyanate-labeled anti-DC-SIGN antibody (anti-human CD209; clone eB-
The effect of L. infantum on DC-SIGN-dependent capture and transfer of HIV-1 was measured by first pulsing DC-SIGN 3.3 ϫ 10 fore HIV-1. DC-SIGN + cells either were not preincubated or were preincubated with L. infantum amastigotes (5 or 10 parasites/target cell) for 1 h at 37ЊC, and free parasites were washed out with PBS. Cells were then briefly exposed to JR-CSF virus (25 ng of p24/ cells) for 2 h at 37ЊC. Next, cells 6 1 ϫ 10 were extensively washed with PBS to remove untrapped pathogens and were cocultured with either TZM-bl indicator cells ) were first exposed to L. infantum amas- 6 1 ϫ 10 tigotes for 1 h at 37ЊC. Unbound parasites were washed out with PBS. Next, JR-CSF virus (25 ng of p24/ cells) was added, 6 1 ϫ 10 and the parasite/HIV-1/cell mixture was incubated for another 2 h at 37ЊC. After extensive washes with PBS, the cell pellets were lysed, and the amounts of cell-associated virus were quantified by estimating p24 content. Results are expressed as the mean ‫ע‬ SD values of samples tested in triplicate. Statistical significance (P ! .05) of differences between groups was determined by analysis of variance.
Results. Exposure of B-THP-1/DC-SIGN cells to L. infantum amastigotes led to a dose-dependent diminution of DC-SIGN staining. For example, DC-SIGN expression was reduced by and when parasite-cell ratios of 65% ‫ע‬ 6.6% 31% ‫ע‬ 8. Discussion. There is now compelling evidence that DC-SIGN is involved in the binding and internalization of Leishmania parasites in both the promastigote and amastigote infective stages [2, 9] . Thus, our results suggesting that L. infantum amastigotes interact with DC-SIGN are perfectly in line with the notion that DC-SIGN plays a role in pathogen-DC interactions through its affinity for natural surface glycans found on the surface of this human pathogen. The present study was focused on L. infantum, because infection with this Leishmania species is the third most frequent parasitic disease in HIV-1-infected individuals, after Toxoplasma gondii and Cryptosporidium parvum infection. Previous studies have investigated possible Leishmania/DC-SIGN interactions through the use of fluorescence-labeled parasites in combination with blocking agents such as anti-DC-SIGN antibodies and soluble mannan [2, 9] , whereas we used a technical strategy that relied on incubation of DC-SIGN + cells with Leishmania amastigotes, followed by staining with anti-DC-SIGN antibody. This procedure provided direct useful information on both the intensity of DC-SIGN cell-surface expression and the percentage of DC-SIGN binding sites that were bound specifically by Leishmania parasites. Moreover, this method allowed us to demonstrate that the L. infantum/DC-SIGN association is strong, since it resisted extensive and vigorous washes. Our virus transfer experiments further revealed that HIV-1 transfer to target cells, such as primary CD4 + T cells, was significantly reduced when DC-SIGN + cells, including primary human iMDDCs, were first exposed to the parasites before pulsing with HIV-1. The diminished capacity of DC-SIGN + cells to transfer HIV-1 was linked with a reduction in virus capture. These findings are reminiscent of previous observations of antibodies directed against DC-SIGN that have been shown to inhibit the uptake of both human pathogens by DCs [2, 9, 10] . It is important to emphasize that DCs were exposed to Leishmania parasites for a short period, therefore suggesting that the reduced HIV-1 transfer is most likely attributable to an effect whereby cell-surface DC-SIGN is occupied by L. infantum and is no longer accessible to HIV-1. It can also be proposed that DC-SIGN is internalized upon L. infantum binding. Additional studies are warranted to shed light on this issue.
At first sight, the demonstration that Leishmania parasites in the amastigote form impair HIV-1 transfer from DCs to target cells seems to constitute a paradox, since virus load in HIV-1/Leishmania-coinfected patients is higher than that in HIV-1-infected control individuals without coinfection. However, some explanations can be proposed for this apparent contradiction. For example, although DC-SIGN plays an important role in the process of HIV-1 infection in trans, it must be stressed that DC-SIGN affects virus transfer only from cells that are either not susceptible or weakly susceptible to productive HIV-1 infection. It is now well established that HIV-1 entry into target cells occurs mainly through the interaction of the viral envelope protein gp120 with cell-surface receptor CD4 and chemokine coreceptors. Thus, the reported augmentation of HIV-1 load in patients who are also infected with Leishmania parasites may be the consequence of a parasite-mediated increase in CCR5 expression [11] , an effect that may predominate over the impact on the DC-SIGN trans-infection pathway. Interestingly, patients with active visceral leishmaniasis showed increased surface expression of CXCR4 on circulating CD4 + T cells, compared with that in healthy donors, a process that could render T lymphocytes more susceptible to HIV-1 infection [12] .
To the best of our knowledge, there are no published studies that have included quantitative analyses of L. infantum amastigotes in a statistically significant number of HIV-1-infected patients. Therefore, it is still unknown whether parasites can be found at levels sufficiently high to possibly interfere with transmission of HIV-1. However, in studies of limited numbers of individuals, it has been shown that HIV-1-infected individuals carry many more amastigotes in their peripheral circulation than do their HIV-1-negative counterparts [13, 14] , Moreover, data from in vitro studies indicate that HIV-1 enhances the intracellular growth of Leishmania parasites [15] . Therefore, it can be proposed that our findings bear some physiological relevance in the setting of coinfected patients.
Altogether, our results highlight the very complex nature of possible interactions between Leishmania parasites and HIV-1 in dually infected patients. To the best of our knowledge, this is the first study to propose that the demonstrated competition between HIV-1 and L. infantum amastigotes for DC-SIGN binding might impact the immunological and pathological events associated with HIV-1 infection. This observation certainly expands our knowledge of the relationship between these 2 human pathogens. Since anti-DC-SIGN antibodies can block the uptake of both human pathogens, novel therapeutic strategies could be designed that use, for example, soluble receptors for blocking interactions between DCs and these 2 microorganisms.
